Melanie Desbois - IGM Biosciences | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 43 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 1899: Novel Combinations of Aplitabart, a DR5 Agonist IgM Antibody, with ADCs or Chemotherapeutic Agents Lead to Robust Anti-Tumor Responses in Solid Tumor Models

Mélanie Desbois,Susan E. Calhoun,Kevin C. Hart, Carolyn R. Denson,Poonam Yakkundi,Thomas J. Matthew,Maya K. Leabman,Sanela Bilic,Genevive Hernandez,Eric W. Humke, Albert F. Candia,Bruce Keyt,Angus M. Sinclair,Maya F. Kotturi,Beatrice T. Wang

Cancer Researchno. 6_Supplement (2024): 1899-1899

Cited0Views0Bibtex

Supplementary Figure 2 from IL-18 Induces PD-1–Dependent Immunosuppression in Cancer

Magali Terme,Evelyn Ullrich,Laetitia Aymeric,Kathrin Meinhardt,Mélanie Desbois,Nicolas Delahaye,Sophie Viaud,Bernard Ryffel,Hideo Yagita, Gilles Kaplanski,Armelle Prévost-Blondel,Masashi Kato,Joachim L. Schultze, Eric Tartour,Guido Kroemer, Nathalie Chaput,Laurence Zitvogel

crossref（2023）

Cited0Views0Bibtex

Abstract 6123: Characterization of the Synergistic Tumor Cytotoxicity of Agonistic DR5 IgM Antibody IGM-8444 with Chemotherapeutic Agents

Beatrice T. Wang,Thomas J. Matthew,Poonam Yakkundi,Miho Oyasu,Mélanie Desbois,Susan E. Calhoun, Ling Wang,Tasnim Kothambawala, Devinder K. Ubhi,Marvin S. Peterson,Eric W. Humke,Maya F. Kotturi,Bruce A. Keyt,Angus M. Sinclair

Cancer Research（2023）

Cited0Views0Bibtex

Abstract A137: Pharmacokinetics and Pharmacodynamics of IGM-8444, a First-in-class Engineered Pentameric DR5-targeting Agonist IgM Monoclonal Antibody, in Patients with R/R and Newly Diagnosed Cancers

Genevive Hernandez,Sanela Bilic, Yinghui Guan, John Serrati,Shoumo Bhattacharya,Béatrice Wang,Maya F. Kotturi,Miho Oyasu,Mélanie Desbois, Yuan Cao,Eric W. Humke, Sean Ahern,Angus M. Sinclair,Susanna V. Ulahannan,Vivek Subbiah, M. Pelster,Patricia LoRusso,Gerald S. Falchook,Judy Wang, Minal Barve,Jaspreet Singh Grewal,Warren Chow,Jason T. Henry,Michael Cecchini, Chris H. Takimoto,Maya Leabman

Molecular cancer therapeuticsno. 12_Supplement (2023): A137-A137

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn